Gregory Richard J.
Related Filers (3)
Ownership (21)
3
Thursday, 7/7/2022
ProMIS Neurosciences Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/17/2022
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2020
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/29/2020
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/10/2019
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/25/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/4/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/8/2019
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/29/2018
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/27/2018
Homology Medicines, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 2/23/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/9/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/8/2018
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2017
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2016
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/14/2015
IMMUNOGEN INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/7/2015
IMMUNOGEN INC: Initial statement of beneficial ownership of securities